
IMVT Valuation
Immunovant Inc
- Overview
- Forecast
- Valuation
- Earnings
IMVT Relative Valuation
IMVT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IMVT is overvalued; if below, it's undervalued.
Historical Valuation
Immunovant Inc (IMVT) is now in the Fair zone, suggesting that its current forward PS ratio of 321.80 is considered Fairly compared with the five-year average of -11.89. The fair price of Immunovant Inc (IMVT) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:18.32
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
4.42
P/B
Median3y
7.57
Median5y
6.25
-12.27
FCF Yield
Median3y
-8.48
Median5y
-8.81
Competitors Valuation Multiple
The average P/S ratio for IMVT's competitors is 86.21, providing a benchmark for relative valuation. Immunovant Inc Corp (IMVT) exhibits a P/S ratio of 321.80, which is 273.28% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch

ZI
Zoominfo Technologies Inc
0
USD
+9.31%

HTGC
Hercules Capital Inc
19.430
USD
-0.26%

TPH
Tri Pointe Homes Inc (Delaware)
31.730
USD
-9.83%

CLSK
CleanSpark Inc
12.340
USD
-0.88%

SSL
Sasol Ltd
5.370
USD
-0.19%

GPOR
Gulfport Energy Corp
173.350
USD
+2.57%

CRNX
Crinetics Pharmaceuticals Inc
30.410
USD
-1.84%

CRSP
CRISPR Therapeutics AG
66.060
USD
-3.05%

OR
OR Royalties Inc
27.900
USD
-1.76%

IGT
International Game Technology PLC
0
USD
+2.95%
FAQ

Is Immunovant Inc (IMVT) currently overvalued or undervalued?
Immunovant Inc (IMVT) is now in the Fair zone, suggesting that its current forward PS ratio of 321.80 is considered Fairly compared with the five-year average of -11.89. The fair price of Immunovant Inc (IMVT) is between to according to relative valuation methord.

What is Immunovant Inc (IMVT) fair value?

How does IMVT's valuation metrics compare to the industry average?

What is the current P/B ratio for Immunovant Inc (IMVT) as of Jul 25 2025?

What is the current FCF Yield for Immunovant Inc (IMVT) as of Jul 25 2025?

What is the current Forward P/E ratio for Immunovant Inc (IMVT) as of Jul 25 2025?
